A 12-year-old girl’s treatment journey shows why nutrition support in paediatric cancer must continually adapt to symptoms, treatment changes and the child’s ability to function.
In paediatric oncology, nutrition is often framed as a simple matter of whether a child is eating enough. In reality, the picture is far more complicated. A consensus statement in the journal Cancers says malnutrition is common in children with cancer and can affect both quality of life and survival, while a scoping review in Supportive Care in Cancer notes that screening and treatment practices still vary widely between hospitals. Against that backdrop, one clinician’s account of a 12-year-old girl with Ewing sarcoma shows how nutrition care has to shift repeatedly as treatment and symptoms change.
Her case began with major physical vulnerability. After surgery in the lower spine, she went through chemotherapy and radiotherapy, then later required more intensive oncological treatment when the disease became active again. By the time she entered nutrition care, she had lost substantial weight and was markedly weak. Her feeding plan was still changing, and her laboratory results reflected the strain of prolonged treatment, but her care team judged her condition by more than blood work alone, taking into account intake, symptoms and functional status.
The early priority was to move her away from tube feeding and back towards eating by mouth. That transition was achieved within about a week, but it did not mark the end of the nutrition challenge. Over the following months, her symptoms shifted repeatedly: diarrhoea, constipation, nausea, bloating, oral soreness, difficulty chewing, taste changes, pain and profound fatigue all affected what she could manage. At one point, even drinking water was uncomfortable. In practice, that meant the diet plan had to be adjusted again and again, with textures altered, food choices changed and energy density increased whenever she could tolerate only small amounts.
That kind of individualised approach is consistent with recent consensus guidance. A 2024 statement from the Polish Society of Clinical Nutrition of Children and the Polish Society of Paediatric Oncology and Haematology stresses regular nutritional assessment and support tailored to the child’s growth and development. Another consensus article, published in 2024, lays out an escalation pathway for children aged four to 18, with the aim of preserving growth, maintaining nutritional status and preventing longer-term harm. The broader message from these papers is that there is no single meal plan that works for every phase of treatment.
Her progress was also a reminder that weight alone does not tell the whole story. After falling from about 45 kilograms to 31 kilograms, her weight later stayed roughly stable for weeks, which was encouraging but not enough to suggest full recovery. Later observations showed loss of body fat and cachexia, underscoring the difference between a stable number on the scales and restored nutritional reserves. At the same time, her ability to eat orally improved, her energy lifted on some days and she began to reconnect with ordinary life, meeting friends, travelling for several hours and returning to study.
The course was far from smooth. Following radiotherapy, she developed severe mucositis, making even water painful at times. Chemotherapy then brought a severe bout of diarrhoea, followed later by constipation, abdominal cramps and further loss of appetite. Her blood counts also shifted, and treatment was at one point delayed because of low platelets. Studies of mucositis in paediatric cancer care have long noted the lack of highly effective prevention or treatment, leaving supportive care and symptom management at the centre of day-to-day nutrition decisions.
For the clinician describing her case, that is the central lesson of paediatric oncology nutrition: it is not just about calories, protein or body weight. A child may appear to be meeting a target on paper while still struggling to eat, function or keep up with everyday life. Being able to sit with friends, travel, open a book or prepare for examinations may not appear in a standard nutrition chart, but they are meaningful signs of resilience. In this case, nutrition support was not a fixed prescription so much as a moving response to what the child could tolerate at each stage, with the goal of preserving strength, function and the chance to continue ordinary life as treatment went on.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
